• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD44 在癌症化疗耐药中的作用:简要综述。

The role of CD44 in cancer chemoresistance: A concise review.

机构信息

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Eur J Pharmacol. 2021 Jul 15;903:174147. doi: 10.1016/j.ejphar.2021.174147. Epub 2021 May 5.

DOI:10.1016/j.ejphar.2021.174147
PMID:33961871
Abstract

CD44 is a cell surface adhesion molecule, which is overexpressed on cancer stem cells. The interaction of CD44 with hyaluronan is responsible for tumor development, metastasis, and expression of the chemoresistant phenotype. The overexpression of CD44 impedes the cytotoxic effect of chemotherapy medications in various cancers. Therefore, the high expression of CD44 is associated with a poor prognosis in affected patients. This high expression of CD44 in various cancers has provided an ample opportunity for the treatment of patients with chemoresistant malignancy. This review aims to demonstrate the various cross-talk between CD44 and intracellular and extracellular factors and highlight its role in developing chemoresistant tumors in some troublesome cancers.

摘要

CD44 是一种细胞表面黏附分子,在肿瘤干细胞中过表达。CD44 与透明质酸的相互作用是肿瘤发生、转移和表达化疗耐药表型的原因。CD44 的过表达会阻碍各种癌症中化疗药物的细胞毒性作用。因此,CD44 的高表达与受影响患者的预后不良相关。在各种癌症中 CD44 的高表达为治疗耐药性恶性肿瘤的患者提供了充分的机会。本综述旨在展示 CD44 与细胞内和细胞外因素之间的各种相互作用,并强调其在某些棘手癌症中形成化疗耐药肿瘤的作用。

相似文献

1
The role of CD44 in cancer chemoresistance: A concise review.CD44 在癌症化疗耐药中的作用:简要综述。
Eur J Pharmacol. 2021 Jul 15;903:174147. doi: 10.1016/j.ejphar.2021.174147. Epub 2021 May 5.
2
Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.乳腺癌细胞的长期药物选择和癌症干细胞特征的富集。
J Natl Cancer Inst. 2010 Nov 3;102(21):1637-52. doi: 10.1093/jnci/djq361. Epub 2010 Oct 8.
3
Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells.靶向敲低 CD44 可提高耐顺铂的非小细胞肺癌细胞对顺铂的敏感性。
Cancer Chemother Pharmacol. 2019 Mar;83(3):399-410. doi: 10.1007/s00280-018-3737-y. Epub 2018 Dec 4.
4
CD44: More than a mere stem cell marker.CD44:不仅仅是一个单纯的干细胞标志物。
Int J Biochem Cell Biol. 2016 Dec;81(Pt A):166-173. doi: 10.1016/j.biocel.2016.09.009. Epub 2016 Sep 15.
5
Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.透明质酸与CD44的相互作用促进癌干细胞中的致癌信号传导、微小RNA功能、化学抗性和辐射抗性,从而导致肿瘤进展。
Adv Cancer Res. 2014;123:255-75. doi: 10.1016/B978-0-12-800092-2.00010-1.
6
Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.可变剪接调节癌症侵袭性:在 EMT/转移和化疗耐药中的作用。
Mol Biol Rep. 2021 Jan;48(1):897-914. doi: 10.1007/s11033-020-06094-y. Epub 2021 Jan 5.
7
Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.基质透明质酸介导的CD44信号激活、表观遗传调控与头颈癌干细胞的化疗耐药性
Int J Mol Sci. 2017 Aug 24;18(9):1849. doi: 10.3390/ijms18091849.
8
Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment.紫杉醇处理后卵巢癌细胞中的表型修饰。
Cancer Med. 2013 Dec;2(6):751-62. doi: 10.1002/cam4.115. Epub 2013 Aug 27.
9
CD44/CD24 Expression as predictors of ovarian cancer chemoresistance: immunohistochemistry and flow cytometry study.CD44/CD24 表达作为卵巢癌化疗耐药的预测因子:免疫组织化学和流式细胞术研究。
J Egypt Natl Canc Inst. 2022 Oct 24;34(1):44. doi: 10.1186/s43046-022-00143-2.
10
Cancer stem cell epigenetics and chemoresistance.癌症干细胞的表观遗传学与化疗耐药性。
Epigenomics. 2009 Oct;1(1):63-79. doi: 10.2217/epi.09.4.

引用本文的文献

1
Resveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and Mitigating Metastasis.白藜芦醇:使CD44 + 宫颈癌细胞对卡铂敏感并减轻转移
Cancer Med. 2025 Sep;14(17):e71194. doi: 10.1002/cam4.71194.
2
Enhanced cancer cell sorting using lab-on-a-disk pattern design with magnetic and centrifugal forces.利用磁动力和离心力的盘上实验室模式设计增强癌细胞分选
Front Bioeng Biotechnol. 2025 Aug 1;13:1611313. doi: 10.3389/fbioe.2025.1611313. eCollection 2025.
3
Advances in Chondroitin Sulfate-Based Nanoplatforms for Biomedical Applications.
用于生物医学应用的基于硫酸软骨素的纳米平台的进展
Int J Nanomedicine. 2025 Aug 9;20:9857-9881. doi: 10.2147/IJN.S533559. eCollection 2025.
4
CXCR4-targeted theranostics in acute leukemia: disrupting leukemic cell-microenvironment interactions with pentixafor and pentixather.急性白血病中靶向CXCR4的诊疗一体化:利用喷替沙氟和喷替沙肽破坏白血病细胞与微环境的相互作用
Med Oncol. 2025 Aug 4;42(9):402. doi: 10.1007/s12032-025-02924-w.
5
Moesin silencing enhances the radiosensitivity of glioblastoma by inhibiting DNA damage repair via CD44/AKT1 signaling pathway.肌动蛋白结合蛋白沉默通过CD44/AKT1信号通路抑制DNA损伤修复,从而增强胶质母细胞瘤的放射敏感性。
Discov Oncol. 2025 Jul 31;16(1):1451. doi: 10.1007/s12672-025-03266-9.
6
Hollow Manganese Dioxide-Based Nanodelivery System for Paclitaxel to Enhance Therapeutic Efficacy in Breast Cancer Treatment.用于紫杉醇的中空二氧化锰基纳米递送系统,以增强乳腺癌治疗的疗效
ACS Omega. 2025 Jul 10;10(28):30386-30396. doi: 10.1021/acsomega.5c01922. eCollection 2025 Jul 22.
7
CD44 Variant Expression in Follicular Cell-Derived Thyroid Cancers: Implications for Overcoming Multidrug Resistance.CD44变异体在滤泡细胞源性甲状腺癌中的表达:对克服多药耐药性的意义
Molecules. 2025 Apr 24;30(9):1899. doi: 10.3390/molecules30091899.
8
Carotenoids Modulate FoxO-Induced Cell Cycle Awrrest in Human Cancer Cell Lines: A Scoping Review.类胡萝卜素对人癌细胞系中FoxO诱导的细胞周期阻滞的调节作用:一项综述。
Food Sci Nutr. 2025 Mar 28;13(4):e70100. doi: 10.1002/fsn3.70100. eCollection 2025 Apr.
9
In Vitro, Anti-Colon Cancer Activity of Green Dumbbell-Shaped Rhododendron luteum-Based Carbon Dots.基于黄色杜鹃绿哑铃形碳点的体外抗结肠癌活性
ChemistryOpen. 2025 May;14(5):e202400303. doi: 10.1002/open.202400303. Epub 2025 Jan 29.
10
High CD44 expression and enhanced E-selectin binding identified as biomarkers of chemoresistant leukemic cells in human T-ALL.高CD44表达和增强的E-选择素结合被确定为人类T细胞急性淋巴细胞白血病中化疗耐药白血病细胞的生物标志物。
Leukemia. 2025 Feb;39(2):323-336. doi: 10.1038/s41375-024-02473-7. Epub 2024 Nov 24.